Σύνολο αποτελεσμάτων: 94, εμφανίζονται 61 - 70
Αποτελέσματα ανά σελίδα:  10  25  50  100
Ταξινόμηση ανά: Ημερομηνία · Επισκέψεις · Τίτλο
61 Non-TPMT determinants of azathioprine toxicity in inflammatory bowel disease
E.V. Tsianos,
Azathioprine (AZA) follows three metabolic routes: the first is the route to 6-thioguanine (TGN) catalyzed by thiopurine methyltransferase (TPMT) and the other two routes are S-methylation to methylme...
62 Obstruction and pseudo-obstruction in inflammatory bowel disease
K.H. Katsanos V.E. Tsianos M. Maliouki M. Adamidi I. Vagias E.V. Tsianos,
Intestinal obstruction and pseudo-obstruction represents a severe complication and a potential emergency in Crohn’s disease and ulcerative colitis. Such intestinal complications are of great importanc...
63 Optimal staging of esophageal cancer
E. Vazquez-Sequeiros,
EUS and EUS-FNA represent the most accurate method for locoregional staging of esophageal carcinoma, and should be performed for local staging in those patients who are good surgical candidates and ot...
64 Pathogenesis of Fulminant Hepatic Failure
Aspasia Soultati S. P. Dourakis,
Acute liver failure (ALF) is characterized by severe and sudden liver cell dysfunction leading to coagulopathy and hepatic encephalopathy in previously healthy persons. A critical degree of liver cell...
65 Pathology of nonalcoholic fatty liver disease
Tiniakos, Ch. Kittas, D.G.,
Nonalcoholic fatty liver disease (NAFLD) may be the most common cause of chronic liver disease in Western countries, with an estimated prevalence of up to 24% in the general population. NAFLD is consi...
66 Pathophysiology and management of acute liver failure
E. Pyleris G. Giannikopoulos K. Dabos,
This is a review of the latest up to date information on Acute Liver Failure, a multi organic syndrome sometimes with a fatal outcome, if not diagnosed and treated at the right time. The review pays a...
67 Patterns and clinical relevance of antibody responses during adalimumab therapy
K.H. Katsanos V. Tsianos I. Vagias E.V. Tsianos,
All biologic therapies have the potential to induce immunogenicity. Homology reduces antigenicity, but‘humanization’ does not equate with homology and human antibodies may be also immunogenic. Despite...
68 Perianal Fistulizing Crohn’s disease: imaging modalities and therapeutic challenges
K.H. Katsanos A.A. Papathanasopoulos D.K. Christodoulou E.V. Tsianos,
Perianal involvement in Crohn’s disease is not infrequent. Risk factors for the development of fistulas include a high activity of CD, a fibrostenotic phenotype, genetic markers such as the HLA-DRB1 a...
69 Peritoneal tuberculosis
Mimidis, K. Ritis, G. Kartalis, K.,
Tuberculosis (TB) can involve any part of the gastrointestinal tract and is the sixth most frequent site of extrapulmonary involvement. Both the incidence and severity of abdominal tuberculosis (AT) a...
70 Polyflex stents for malignant esophageal strictures: An overview
G. Lazaraki I. Pilpilidis P. Katsinelos,
Self-expandable metallic stent (SEMS) placement has been widely accepted to be a safe and effective option for palliation of the symptoms caused by malignant esophageal strictures and for occlusion of...